Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$86.20

-1.49 (-1.70%)

16:34
10/23/19
10/23
16:34
10/23/19
16:34

Bluebird Bio chief strategy officer Jeffrey Walsh to step down

bluebird bio announced that Jeffrey T. Walsh, chief strategy officer, has decided to transition from his current role effective January 6, 2020. Both Chip Baird, CFO, and Joanne Smith-Farrell, chief business officer, will assume broader corporate development and strategic responsibilities as bluebird continues to deliver on its mission for patients.

  • 07

    Dec

BLUE Bluebird Bio
$86.20

-1.49 (-1.70%)

08/12/19
WBLR
08/12/19
DOWNGRADE
WBLR
Market Perform
William Blair downgrades Bluebird Bio, calls Zynteglo launch 'slow mover'
William Blair analyst Raju Prasad downgraded Bluebird Bio to Market Perform from Outperform saying he's taking a conservative view on the company's transition from a development-stage company to a commercial-stage company. Based on the reimbursement model, the analyst believes that the Zynteglo launch is likely to be a "slow mover." Further, Prasad altered his model for bb2121-bb21217 to reflect the increased BCMA competition from both autologous and allogeneic cell therapy approaches that he says are moving faster through the clinic than he initially anticipated.
08/12/19
08/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. NetEase (NTES) downgraded to Neutral from Buy at Goldman Sachs with analyst Bill Liu citing the company's Q2 revenues miss, mainly on soft online games growth. 2. Occidental Petroleum (OXY) downgraded to In Line from Outperform at Evercore ISI with analyst Doug Terreson saying the company's "pledge" for greater capital discipline and enhanced corporate governance "proved fleeting" with the significant decline in return on capital employed due to the Anadarko acquisition. 3. Adesto Technologies (IOTS) downgraded to Market Perform from Outperform at Northland with analyst Gus Richard saying the company has $34M of high interest debt and needs $10M to pay an earnout by year end, but he thinks the company is holding off on an offering until it reports a "strong" third quarter that will be boosted by an airpod win at Apple (AAPL). 4. Bluebird Bio (BLUE) downgraded to Market Perform from Outperform at William Blair with analyst Raju Prasad saying he's taking a conservative view on the company's transition from a development-stage company to a commercial-stage company. 5. Cemex (CX) downgraded to Market Perform from Outperform at BBVA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/19
STFL
09/30/19
INITIATION
Target $109
STFL
Hold
Bluebird Bio initiated with a Hold at Stifel
Stifel analyst Benjamin Burnett initiated Bluebird Bio with a Hold rating and a price target of $109. The analyst is concerned that the launch of the company's lead product Zynteglo will be slow, which places a risk on it meeting consensus expectations. Burnett adds that the the bull case on Bluebird Bio is hard to justify because of the tough competition in multiple myeloma.
10/09/19
STFL
10/09/19
NO CHANGE
STFL
Hold
Bluebird Hem A collaboration not stock moving, but worth monitoring, says Stifel
Stifel analyst Benjamin Burnett said he does not expect news that Blubird Bio (BLUE) is entering the Hemophila A race via a collaboration with Novo Nordisk (NVO) to be stock moving, but he does think it is "certainly worth monitoring." Biomarin's (BMRN) gene therapy candidate Valrox sets "the bar for genetic medicines in heme A today," said Burnett, who noted that gene therapies from Spark (ONCE) and Pfizer (PFE) are also in the clinic. However, "there does appear to be room for efficacy improvement as none of the clinical data generated from genetic medicines to date is a clear home run," Burnett added in his note to investors. He keeps a Hold rating on Bluebird Bio shares.

TODAY'S FREE FLY STORIES

TORC

resTORbio

$1.35

-6.58 (-82.98%)

10:51
11/15/19
11/15
10:51
11/15/19
10:51
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSN

VeriSign

$186.74

-0.36 (-0.19%)

10:50
11/15/19
11/15
10:50
11/15/19
10:50
Options
Delta neutral call buyers in VeriSign December »

Delta neutral call buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$17.47

0.34 (1.98%)

, UA

Under Armour

$15.76

0.2 (1.29%)

10:47
11/15/19
11/15
10:47
11/15/19
10:47
Hot Stocks
Under Armour says 'always in compliance' with GAAP amid scrutiny »

Under Armour said earlier…

UAA

Under Armour

$17.47

0.34 (1.98%)

UA

Under Armour

$15.76

0.2 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$204.28

-5.605 (-2.67%)

10:40
11/15/19
11/15
10:40
11/15/19
10:40
Options
Nvidia options volume 7x normal as shares whip post earnings »

Nvidia options volume 7x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

10:30
11/15/19
11/15
10:30
11/15/19
10:30
On The Fly
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

CS

Credit Suisse

$12.98

0.135 (1.05%)

NVDA

Nvidia

$202.92

-6.96 (-3.32%)

OSTK

Overstock.com

$8.30

0.12 (1.47%)

AMD

AMD

$39.05

0.69 (1.80%)

DPW

DPW Holdings

$1.16

-0.06 (-4.92%)

KODK

Kodak

$2.35

-0.02 (-0.84%)

RIOT

Riot Blockchain

$1.53

-0.05 (-3.16%)

TEUM

Pareteum

$0.39

-0.006 (-1.50%)

SRAX

Social Reality

$1.56

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 09

    Dec

  • 06

    Jan

PPL

PPL Corp.

$33.72

0.1 (0.30%)

10:30
11/15/19
11/15
10:30
11/15/19
10:30
Options
Size call spread in PPL Corp reloads short calls »

Size call spread in PPL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$292.26

2.58 (0.89%)

, HPQ

HP Inc.

$20.13

0.01 (0.05%)

10:29
11/15/19
11/15
10:29
11/15/19
10:29
Recommendations
Netflix, HP Inc., Aramark analyst commentary  »

Gordon Haskett says…

NFLX

Netflix

$292.26

2.58 (0.89%)

HPQ

HP Inc.

$20.13

0.01 (0.05%)

ARMK

Aramark

$43.38

0.08 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 26

    Nov

  • 09

    Dec

  • 10

    Dec

10:25
11/15/19
11/15
10:25
11/15/19
10:25
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

DTIL

Precision BioSciences

$11.35

-0.45 (-3.81%)

10:25
11/15/19
11/15
10:25
11/15/19
10:25
Conference/Events
Precision BioSciences participates in a conference call with BTIG »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 07

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

10:20
11/15/19
11/15
10:20
11/15/19
10:20
Options
Put sale in VIX appears to exit two-week position for 64% gain »

Put sale in VIX appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
11/15/19
11/15
10:20
11/15/19
10:20
General news
The September business inventory report undershot estimates »

The September business…

AMRN

Amarin

$22.68

1.19 (5.54%)

10:19
11/15/19
11/15
10:19
11/15/19
10:19
On The Fly
One analyst thinks Amarin could rise toward $50 after positive FDA panel vote »

Shares of Amarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/15/19
11/15
10:17
11/15/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAYS

Paysign

$10.74

-0.53 (-4.70%)

, WAB

Wabtec

$79.36

0.82 (1.04%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

PAYS

Paysign

$10.74

-0.53 (-4.70%)

WAB

Wabtec

$79.36

0.82 (1.04%)

AWK

American Water

$117.25

-0.65 (-0.55%)

RIGL

Rigel Pharmaceuticals

$2.32

0.035 (1.53%)

LPSN

LivePerson

$37.54

1.12 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 25

    Nov

  • 26

    Nov

  • 07

    Dec

  • 10

    Dec

MITK

Mitek Systems

$7.35

-0.35 (-4.55%)

, AGCO

Agco

$80.01

-0.11 (-0.14%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MITK

Mitek Systems

$7.35

-0.35 (-4.55%)

AGCO

Agco

$80.01

-0.11 (-0.14%)

GPOR

Gulfport Energy

$2.84

-0.26 (-8.39%)

CNP

CenterPoint Energy

$25.31

-1.37 (-5.13%)

NVDA

Nvidia

$204.18

-5.7 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 13

    Dec

  • 06

    Jan

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$92.55

2.07 (2.29%)

, AMAT

Applied Materials

$61.45

4.56 (8.02%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

QCOM

Qualcomm

$92.55

2.07 (2.29%)

AMAT

Applied Materials

$61.45

4.56 (8.02%)

GRUB

GrubHub

$38.99

0.47 (1.22%)

BCRX

BioCryst

$1.65

0.07 (4.43%)

NVDA

Nvidia

$204.69

-5.19 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 06

    Jan

  • 14

    Nov

AM

Antero Midstream

$5.34

-0.035 (-0.65%)

10:15
11/15/19
11/15
10:15
11/15/19
10:15
Options
Antero Midstream put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
11/15/19
11/15
10:10
11/15/19
10:10
General news
U.S. business inventories were flat in September, with sales slipping -0.2% »

U.S. business inventories…

FBHS

Fortune Brands

$63.32

0.18 (0.29%)

10:09
11/15/19
11/15
10:09
11/15/19
10:09
Downgrade
Fortune Brands rating change  »

Fortune Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.66

1.17 (5.44%)

10:05
11/15/19
11/15
10:05
11/15/19
10:05
Options
Amarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

10:05
11/15/19
11/15
10:05
11/15/19
10:05
General news
The industrial production report sharply undershot estimates »

The industrial production…

10:02
11/15/19
11/15
10:02
11/15/19
10:02
General news
Business Inventories data reported »

September Business…

NCNA

NuCana

$5.59

(0.00%)

10:02
11/15/19
11/15
10:02
11/15/19
10:02
Recommendations
NuCana analyst commentary  »

NuCana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KZR

Kezar Life Sciences

$2.59

(0.00%)

10:02
11/15/19
11/15
10:02
11/15/19
10:02
Conference/Events
Kezar Life Sciences management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.